Syntropic CoreLab on LinkedIn: Vesper Duo Venous Stent System’s VIVID Pivotal Study Completes Enrollment…

452 followers

12mo Edited

We are happy to see this important study completed and the results reported at The VEINS/ The VIVA Foundation Late Breaking Clinical Trial Session. We are honored to provide duplex, IVUS, x-ray, and venographic adjudication. Thanks to Philips for the trust. Mahmood Razavi Heather Hudnut Page Kelly O'Connell, Ph.D. Marc Penna Bruce S. https://lnkd.in/djREkCXT

Vesper Duo Venous Stent System’s VIVID Pivotal Study Completes Enrollment - Endovascular Today

3 Comments

Global Medtech Leader ◆ Board Member ◆ Business Visioning & Strategy ◆ Global Commercialization ◆ M&A

11mo

Congratulations to the entire clinical team who executed (and is continuing to execute) the VIVID trial!

Project Manager | Commercial Real Estate, Real Estate Financing

11mo

Congratulations

See more comments

To view or add a comment, sign in